MedTrace Logo

64Cu-DOTATATE PET-CT-skanning and Infective Endocarditis.

NCT05432427 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2024-12-27

No results posted yet for this study

Summary

The investigators hypothesize that the 64Cu-DOTATATE will show uptake in the infected vegetations on the prosthetic heart valves and increase the accuracy of the right diagnosis - thus increasing the sensitivity and specificity compared to 18F-FDG PET/CT

Conditions

  • Endocarditis
  • Endocarditis;Chronic
  • Endocarditis Acute

Interventions

RADIATION

64Cu-DOTATATE and 18F-FDG

All participants will get a 64Cu-DOTATATE-PET and 18F-FDG-PET/CT.

Sponsors & Collaborators

  • Emil Loldrup Fosbol

    lead OTHER

Principal Investigators

  • Emil L Fosbøl, MD,Ph.d. · Rigshospitalet, Denmark

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-28
Primary Completion
2023-09-29
Completion
2023-09-29

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05432427 on ClinicalTrials.gov